Preserved C-peptide in survivors of COVID-19: Post hoc analysis

Diabetes Obes Metab. 2022 Mar;24(3):570-574. doi: 10.1111/dom.14608. Epub 2021 Dec 15.

Authors

Sophie A Clarke^{1

2}, Maria Phylactou^{1

2}, Bijal Patel¹, Edouard G Mills¹, Beatrice Muzi¹, Chioma Izzi-Engbeaya^{1

2}, Bernard Khoo³, Karim Meeran^{1

2}, Alexander N Comninos^{1

2}, Ali Abbara^{1

2}, Tricia Tan^{1

4}, Nick Oliver^{1

2}, Waljit S Dhillo^{1

2}

Affiliations

¹ Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
² Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.
³ Department of Endocrinology, Division of Medicine, Faculty of Medical Sciences, Royal Free Campus, University College London, London, UK.
⁴ Department of Clinical Biochemistry, Imperial College Healthcare NHS Trust, London, UK.

PMID: 34850532
DOI: 10.1111/dom.14608

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

C-Peptide
COVID-19*
Humans
SARS-CoV-2
Survivors

Substances

C-Peptide

Grants and funding